Compare BYND & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BYND | ORGO |
|---|---|---|
| Founded | 2009 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.6M | 239.3M |
| IPO Year | 2018 | 2016 |
| Metric | BYND | ORGO |
|---|---|---|
| Price | $10.21 | $1.49 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $0.83 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 10.4M | 638.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 24.69 | ★ 1600.00 |
| EPS | ★ N/A | N/A |
| Revenue | $275,496,000.00 | ★ $564,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.36 | $26.27 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $0.40 | $1.54 |
| 52 Week High | $15.47 | $7.08 |
| Indicator | BYND | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 55.82 | 30.07 |
| Support Level | $0.65 | N/A |
| Resistance Level | $15.47 | $2.58 |
| Average True Range (ATR) | 0.75 | 0.09 |
| MACD | -0.71 | 0.00 |
| Stochastic Oscillator | 2.33 | 0.00 |
Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.